ucsf logo

Natasha Spottiswoode, MD

Infectious Diseases
Infectious Diseases Parnassus
415-353-2626
ucsf logo

Natasha Spottiswoode, MD

Infectious Diseases
Infectious Diseases Parnassus
415-353-2626

On this page

Education & training

Board certification

  • Infectious Disease, American Board of Internal Med/Infectious Disease
  • Internal Medicine, American Board of Internal Medicine

Fellowship

  • Infectious Diseases, UCSF Graduate Medical Education

Residency

  • Internal Medicine, UCSF Graduate Medical Education

Degree

  • MD, Columbia University, Vagelos College of Physicians & Surgeons

My expertise

Locations

    Reviews

    Average rating

    4.8
    4.8 out of 5 Stars
    45 ratings
    About provider reviews

    Showing 1-6 of 9 reviews

    Sort by
    • 5 out of 5 Stars
      December 11, 2025

      All contacts have been very attentive to my condition making changes to my medication based on blood tests.

    • 5 out of 5 Stars
      November 19, 2025

      Dr. Spottiswoode and team are great. Always exceed expectations and always personable.

    • 5 out of 5 Stars
      September 25, 2025

      Excellent consult. Exceeded my expectations. Addressed all necessary issues and encouraged additional dialogue around other care related questions.

    • 5 out of 5 Stars
      September 23, 2025

      If I have no problem recommending them

    • 5 out of 5 Stars
      August 10, 2025

      Took the time to explain things that confused me. Listened to my concerns and gave clear reasons for the decisions being talked about for my health and results of CT.

    • 5 out of 5 Stars
      July 29, 2025

      Very Good

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.